Population-based sero-epidemiological estimates of real-world vaccine effectiveness against Omicron infection in an infection-naive population, Hong Kong, January to July 2022
Jonathan J. Lau(Laboratory of Data Discovery for Health), Joseph T. Wu(Cardiovascular Institute of the South), Kenny W. H. Yam(University of Hong Kong), Chao Wu(Shenzhen Bay Laboratory), Leo C. H. Tsang(University of Hong Kong), Kelvin K. H. Kwan(University of Hong Kong), Zacary Y. H. Chai(University of Hong Kong), Kathy Leung(Department of Health), Asmaa Hachim(HKU-Pasteur Research Pole), GM Leung(Hong Kong Science and Technology Parks Corporation), Gaya K. Amarasinghe(Washington University in St. Louis), Tiffany H. K. Lo(University of Hong Kong), Cheuk Kwong Lee(World Health Organization Regional Office for South-East Asia), Sara Chaothai(University of Hong Kong), Eric H. Y. Lau(Deakin University), Masashi Mori(Ishikawa Prefectural University), David S.C. Hui(Chinese University of Hong Kong), Malik Peiris(Biology of Infection), Sophie Valkenburg(Ghent University Hospital), Samuel M. S. Cheng(University of Hong Kong)
Cited by 5
Related Papers
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
|The Lancet|2020|4.9k
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Severe acute respiratory syndrome
|Nature Medicine|2004|1.2k